Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

5,253 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
AENEAS: A Randomized Phase III Trial of Aumolertinib Versus Gefitinib as First-Line Therapy for Locally Advanced or MetastaticNon-Small-Cell Lung Cancer With EGFR Exon 19 Deletion or L858R Mutations.
Lu S, Dong X, Jian H, Chen J, Chen G, Sun Y, Ji Y, Wang Z, Shi J, Lu J, Chen S, Lv D, Zhang G, Liu C, Li J, Yu X, Lin Z, Yu Z, Wang Z, Cui J, Xu X, Fang J, Feng J, Xu Z, Ma R, Hu J, Yang N, Zhou X, Wu X, Hu C, Zhang Z, Lu Y, Hu Y, Jiang L, Wang Q, Guo R, Zhou J, Li B, Hu C, Tong W, Zhang H, Ma L, Chen Y, Jie Z, Yao Y, Zhang L, Jie W, Li W, Xiong J, Ye X, Duan J, Yang H, Sun M, Sun C, Wei H, Li C, Ali SM, Miller VA, Wu Q. Lu S, et al. Among authors: ma r. J Clin Oncol. 2022 May 17:JCO2102641. doi: 10.1200/JCO.21.02641. Online ahead of print. J Clin Oncol. 2022. PMID: 35580297
Reply by Authors.
Ma R, Lee RS, Nguyen JH, Cowan A, Haque TF, You J, Robert SI, Cen S, Jarc A, Gill IS, Hung AJ. Ma R, et al. J Urol. 2022 May 16:101097JU000000000000269103. doi: 10.1097/JU.0000000000002691.03. Online ahead of print. J Urol. 2022. PMID: 35576151 No abstract available.
5,253 results